TruAlt Bioenergy Limited · NSE: TRUALT · BSE: 544545
TruAlt Bioenergy
Quarterly results as filed with BSE. Latest: Q1 FY27 (Apr–Jun 2026), filed 28 Jul 2026.
Q1 FY27 · Consolidated
Revenue
626.88₹ Cr
+106.3% vs year ago
Net profit
59.27₹ Cr
13x vs year ago
EPS, basic
6.67₹
not comparable vs year ago
Net margin
9.5%
+7.9 pts vs year ago
Quarter by quarter
| Quarter | Revenue | YoY | Net profit | YoY | EPS (₹) | Filed |
|---|---|---|---|---|---|---|
| Q1 FY27Apr–Jun 2026 | 626.88 | +106.3% | 59.27 | 13x | 6.67 | 28 Jul 2026 |
| Q4 FY26Jan–Mar 2026 | 595.52 | — | 60.95 | — | 6.99 | 25 Sep 2026 |
| Q3 FY26Oct–Dec 2025 | 713.24 | — | 69.19 | — | 8.07 | 03 Feb 2026 |
| Q2 FY26Jul–Sep 2025 | 114.86 | — | (37.94) | — | (5.37) | 12 Nov 2025 |
| Q1 FY26Apr–Jun 2025 | 303.89 | — | 4.73 | — | 0.67 | 19 Oct 2025 |
Standalone results
| Quarter | Revenue | YoY | Net profit | YoY | EPS (₹) | Filed |
|---|---|---|---|---|---|---|
| Q1 FY27Apr–Jun 2026 | 615.92 | +109.5% | 55.01 | 2140x | 6.41 | 28 Jul 2026 |
| Q4 FY26Jan–Mar 2026 | 603.22 | — | 56.73 | — | 6.62 | 25 Sep 2026 |
| Q3 FY26Oct–Dec 2025 | 703.02 | — | 66.02 | — | 7.70 | 03 Feb 2026 |
| Q2 FY26Jul–Sep 2025 | 104.47 | — | (42.75) | — | (6.04) | 12 Nov 2025 |
| Q1 FY26Apr–Jun 2025 | 293.93 | — | 0.03 | — | 0.00 | 19 Oct 2025 |
10 filings on record for this company.